| Financial Year |
March 31 2023 |
| Monetary Funds |
2,322,304,585.88 |
| Held-for-trading Financial Assets |
23,000,000.00 |
| Notes Receivable |
3,626,902.67 |
| Accounts Receivable |
615,711,080.93 |
| Advances to Suppliers |
59,486,912.56 |
| Other Receivables |
27,195,869.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
692,241,889.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
143,822,572.88 |
| Other Current Assets |
75,963,842.24 |
| Total Current Assets |
4,132,814,510.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
701,041,752.23 |
| Investment Properties |
19,963,030.92 |
| Fixed Assetes |
3,474,510,794.15 |
| Under-construction Projects |
820,226,423.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
302,589,203.16 |
| R&D expenses |
-- |
| Goodwill |
71,545,744.73 |
| Long-Term Deferred and Prepaid Expenses |
47,778,993.03 |
| Deferred Income Tax Assets |
22,816,770.25 |
| Other Non-Current Assets |
376,855,670.20 |
| Sub-Total of Non-Current Assets |
6,021,235,377.04 |
| Total Assets |
10,154,049,887.40 |
| Short-Term Loans |
126,429,408.33 |
| Trading Financial liabilities |
2,650,959.19 |
| Notes Payable |
276,188,113.58 |
| Accounts Payable |
780,424,415.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,648,107.91 |
| Taxes Payable |
13,063,610.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,542,884.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,312,687.77 |
| Other Current Liabilities |
706,518.66 |
| Sub-Total of Current Liabilities |
1,260,637,089.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,000,000.00 |
| Deferred Income Tax Liabilities |
91,275,514.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
189,599,963.18 |
| Total Liabilities |
1,450,237,052.20 |
| Paid-In Capital(Or Share Stock) |
1,390,632,221.00 |
| Capital Surplus |
4,209,096,307.76 |
| Surplus Reserve |
307,201,888.50 |
| LESS:Treasury Stock |
105,009,263.45 |
| Undistributed Profits |
2,578,531,855.28 |
| Minority Stockholder's Interest |
373,018,307.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,330,794,527.37 |
| Owner's Equity（Stockholder's Equity） |
8,703,812,835.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,154,049,887.40 |
